Literature DB >> 15312805

Single oral dose of geranylgeranylacetone for protection against delayed neuronal death induced by transient ischemia.

Minoru Fujiki1, Hidenori Kobayashi, Ryo Inoue, Abe Tatsuya, Keisuke Ishii.   

Abstract

The present study evaluated the potential effect of geranylgeranylacetone (GGA), which is known as an antiulcer agent, against the delayed neuronal death (DND) of hippocampal neurons an otherwise lethal ischemic insult. Pretreatment with single oral GGA (800 mg/kg, 2 days before ischemia) significantly attenuated DND in gerbil hippocampus. These effects of GGA were prevented by the coinjection of MK801, a noncompetitive N-methyl-d-aspartate glutamate receptor antagonist, which indicates that the protection was indeed glutamate receptor activation mediated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312805     DOI: 10.1016/j.brainres.2004.06.031

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Geranylgeranylacetone ameliorated ischemia/reperfusion induced-blood brain barrier breakdown through HSP70-dependent anti-apoptosis effect.

Authors:  Fazhao Li; Xiyu Gong; Binbin Yang
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury.

Authors:  Zaorui Zhao; Alan I Faden; David J Loane; Marta M Lipinski; Boris Sabirzhanov; Bogdan A Stoica
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-14       Impact factor: 6.200

3.  Geranylgeranylacetone attenuates cerebral ischemia-reperfusion injury in rats through the augmentation of HSP 27 phosphorylation: a preliminary study.

Authors:  Kazuya Matsuo; Kohkichi Hosoda; Jun Tanaka; Yusuke Yamamoto; Taichiro Imahori; Tomoaki Nakai; Yasuhiro Irino; Masakazu Shinohara; Takashi Sasayama; Eiji Kohmura
Journal:  BMC Neurosci       Date:  2021-02-08       Impact factor: 3.288

4.  The Cytotoxic Effects of Geranylgeranylacetone Are Attenuated in the High-Glucose Condition.

Authors:  Yuko Nakano; Daisuke Kobayashi; Masao Miyake; Ryoko Kanno; Masahiro Murakawa; Akihiro Hazama
Journal:  Biores Open Access       Date:  2019-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.